Published source snapshot
Ostinol Insta Joint
ZyCal Bioceuticals Healthcare · US label facts
Label IDlbl_dsld_185130_2894afdb104a6f41
Serving size1 Capsule(s)
Serving formCapsule(s)
Retrieved
Scope: source-market status describes the source record, not live availability. Quantities below are label facts and deterministic arithmetic, not a product recommendation.
Original facts and normalized results
| Ingredient | Original label quantity | Requested normalization | Measurement object |
|---|---|---|---|
| Proprietary Blend (Amino Acid/Protein) Cyplexinol Pro Nature's BMP Complex (Form: partially hydrolyzed Collagen, and its associated proteins including Bone Morphogenetic Proteins (Alt. Name: BMPs)); 2 source forms are listed for this row; the row quantity was not apportioned or assigned to any single form.; DSLD row path: root.0; DSLD ingredientId: 207347 | 225 mg | 225 mg / as_labeled | Cyplexinol Pro Nature's BMP Complex |
| 11-keto-beta-boswellic acid DSLD row path: root.1; DSLD ingredientId: 207386 | 150 mg | 150 mg / as_labeled | 3-O-Acetyl-11-Keto-Beta-Boswellic Acid |
| Gelatin Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 3979. | Not stated | missing_quantity | Gelatin |
| Cellulose Listed as an other ingredient; no amount is supplied. DSLD ingredientId: 30788. | Not stated | missing_quantity | Microcrystalline Cellulose |
Label statements
These are explicitly classified as label claims. They are not converted into platform-endorsed scientific conclusions.
- label_claim Formula re: Contains: Ostinol Insta Joint contains Cyplexinol, a complex of proteins naturally found in bones and joints.
- label_claim General: Product/Version Code: rev.052018
- label_claim General Statements: All Other Content: 5X- Modulates inflammation through multiple pathways
- label_claim General Statements: All Other Content: These proteins are functionally involved in the formation of bone and cartilage tissues, while helping the body fight inflammation.
- label_claim Formula re: Contains: Also contains Acetyl-keto-beta-boswellic acid (AKBA) extracted from Boswellia serrata species. Scientific data has shown that AKBA supports bone and joint health by enzyme inhibition associated with inflammatory pathways.
- label_claim FDA Disclaimer Statement: These statements have not been evaluated by the Food and Drug Administration. This product in not intended to diagnose, treat, cure or prevent any disease.
- label_claim Precautions re: All Other: Do not use if inner seal is missing or broken.
- label_claim Brand IP Statement(s) re: (c), (TM), (SM): Patent No. 9,011,930 and 9,173,905
- label_claim Formulation re: Does NOT Contain: Allergens: None.
- label_claim Precautions re: Pregnant or Nursing or Prescription Medications: Warning: Consult a physician before using if pregnant, nursing or on medication.
- label_claim Precautions re: Children: Keep out of the reach of children.
- label_claim FDA Statement of Identity: Dietary Supplement
- label_claim General Statements: All Other Content: Leaders in Natural Bio-Active Proteins
- label_claim Storage: Store in a cool, dry place.
- label_claim Formula re: Contains: Contains Cyplexinol standard grade Std Nature's BMP - Complex
- label_claim FDA Statement of Identity: Bone & Cartilage Stimulating Protein Supplement
- label_claim Suggested/Recommended/Usage/Directions: Suggested dosage: As a supplement take one (1) to two (2) Ostinal Insta Joint capsules one (1) to two (2) times per day or as needed. For maximum joint results, take with Chondrinol.
Ingredient references
Reference pages provide verified source mappings. Unless a real review record exists, they remain reference-only with no medical summary or evidence grade.
Source and version
- Original record
- NIH ODS DSLD label 185130
- Local snapshot
- snap_dsld_185130_2894afdb104a6f41e17c6985
- Content hash
2894afdb104a6f41e17c69850b3862cf9d38fb4c8cf95328013409a5fdece6ee- Source version
- rev.052018
Limitations
- This record reports label facts from a US-market source snapshot, not current inventory or product safety.
- Label quantity comparisons do not establish absorption, efficacy, safety, or clinical equivalence.